The global Irritable Bowel Syndrome (IBS) market size was valued at USD 4874.3 million in 2022 and is forecast to a readjusted size of USD 12470 million by 2029 with a CAGR of 14.4% during review period.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report is a detailed and comprehensive analysis for global Irritable Bowel Syndrome (IBS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Irritable Bowel Syndrome (IBS) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Irritable Bowel Syndrome (IBS) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Irritable Bowel Syndrome (IBS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Irritable Bowel Syndrome (IBS) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Irritable Bowel Syndrome (IBS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Irritable Bowel Syndrome (IBS) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
IBS-D Drug
IBS-C Drug
Others
Women
Men
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Irritable Bowel Syndrome (IBS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Irritable Bowel Syndrome (IBS), with revenue, gross margin and global market share of Irritable Bowel Syndrome (IBS) from 2018 to 2023.
Chapter 3, the Irritable Bowel Syndrome (IBS) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Irritable Bowel Syndrome (IBS).
Chapter 13, to describe Irritable Bowel Syndrome (IBS) research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome (IBS)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Irritable Bowel Syndrome (IBS) by Type
1.3.1 Overview: Global Irritable Bowel Syndrome (IBS) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type in 2022
1.3.3 IBS-D Drug
1.3.4 IBS-C Drug
1.3.5 Others
1.4 Global Irritable Bowel Syndrome (IBS) Market by Application
1.4.1 Overview: Global Irritable Bowel Syndrome (IBS) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Women
1.4.3 Men
1.5 Global Irritable Bowel Syndrome (IBS) Market Size & Forecast
1.6 Global Irritable Bowel Syndrome (IBS) Market Size and Forecast by Region
1.6.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Irritable Bowel Syndrome (IBS) Market Size by Region, (2018-2029)
1.6.3 North America Irritable Bowel Syndrome (IBS) Market Size and Prospect (2018-2029)
1.6.4 Europe Irritable Bowel Syndrome (IBS) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size and Prospect (2018-2029)
1.6.6 South America Irritable Bowel Syndrome (IBS) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Product and Solutions
2.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bausch Health Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Irritable Bowel Syndrome (IBS) Product and Solutions
2.2.4 Allergan Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Irritable Bowel Syndrome (IBS) Product and Solutions
2.3.4 Takeda Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Takeda Recent Developments and Future Plans
2.4 Sucampo Pharmaceuticals (Mallinckrodt)
2.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Details
2.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Major Business
2.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Solutions
2.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments and Future Plans
2.5 Sebela Pharmaceuticals Inc
2.5.1 Sebela Pharmaceuticals Inc Details
2.5.2 Sebela Pharmaceuticals Inc Major Business
2.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Solutions
2.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sebela Pharmaceuticals Inc Recent Developments and Future Plans
2.6 Astellas Pharmaceuticals
2.6.1 Astellas Pharmaceuticals Details
2.6.2 Astellas Pharmaceuticals Major Business
2.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Solutions
2.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Astellas Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Irritable Bowel Syndrome (IBS) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Irritable Bowel Syndrome (IBS) by Company Revenue
3.2.2 Top 3 Irritable Bowel Syndrome (IBS) Players Market Share in 2022
3.2.3 Top 6 Irritable Bowel Syndrome (IBS) Players Market Share in 2022
3.3 Irritable Bowel Syndrome (IBS) Market: Overall Company Footprint Analysis
3.3.1 Irritable Bowel Syndrome (IBS) Market: Region Footprint
3.3.2 Irritable Bowel Syndrome (IBS) Market: Company Product Type Footprint
3.3.3 Irritable Bowel Syndrome (IBS) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Irritable Bowel Syndrome (IBS) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application (2018-2023)
5.2 Global Irritable Bowel Syndrome (IBS) Market Forecast by Application (2024-2029)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2029)
6.2 North America Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2029)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Country
6.3.1 North America Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2029)
6.3.2 United States Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
6.3.3 Canada Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
6.3.4 Mexico Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2029)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2029)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
7.3.1 Europe Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2029)
7.3.2 Germany Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
7.3.3 France Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
7.3.5 Russia Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
7.3.6 Italy Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
8.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Region (2018-2029)
8.3.2 China Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
8.3.3 Japan Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
8.3.4 South Korea Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
8.3.5 India Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
8.3.7 Australia Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
9 South America
9.1 South America Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2029)
9.2 South America Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2029)
9.3 South America Irritable Bowel Syndrome (IBS) Market Size by Country
9.3.1 South America Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2029)
9.3.2 Brazil Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
9.3.3 Argentina Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
10.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2029)
10.3.2 Turkey Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
10.3.4 UAE Irritable Bowel Syndrome (IBS) Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Irritable Bowel Syndrome (IBS) Market Drivers
11.2 Irritable Bowel Syndrome (IBS) Market Restraints
11.3 Irritable Bowel Syndrome (IBS) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Irritable Bowel Syndrome (IBS) Industry Chain
12.2 Irritable Bowel Syndrome (IBS) Upstream Analysis
12.3 Irritable Bowel Syndrome (IBS) Midstream Analysis
12.4 Irritable Bowel Syndrome (IBS) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Irritable Bowel Syndrome (IBS) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Irritable Bowel Syndrome (IBS) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Irritable Bowel Syndrome (IBS) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Bausch Health Company Information, Head Office, and Major Competitors
Table 6. Bausch Health Major Business
Table 7. Bausch Health Irritable Bowel Syndrome (IBS) Product and Solutions
Table 8. Bausch Health Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Bausch Health Recent Developments and Future Plans
Table 10. Allergan Company Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Irritable Bowel Syndrome (IBS) Product and Solutions
Table 13. Allergan Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Allergan Recent Developments and Future Plans
Table 15. Takeda Company Information, Head Office, and Major Competitors
Table 16. Takeda Major Business
Table 17. Takeda Irritable Bowel Syndrome (IBS) Product and Solutions
Table 18. Takeda Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Takeda Recent Developments and Future Plans
Table 20. Sucampo Pharmaceuticals (Mallinckrodt) Company Information, Head Office, and Major Competitors
Table 21. Sucampo Pharmaceuticals (Mallinckrodt) Major Business
Table 22. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product and Solutions
Table 23. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments and Future Plans
Table 25. Sebela Pharmaceuticals Inc Company Information, Head Office, and Major Competitors
Table 26. Sebela Pharmaceuticals Inc Major Business
Table 27. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product and Solutions
Table 28. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Sebela Pharmaceuticals Inc Recent Developments and Future Plans
Table 30. Astellas Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Astellas Pharmaceuticals Major Business
Table 32. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product and Solutions
Table 33. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Astellas Pharmaceuticals Recent Developments and Future Plans
Table 35. Global Irritable Bowel Syndrome (IBS) Revenue (USD Million) by Players (2018-2023)
Table 36. Global Irritable Bowel Syndrome (IBS) Revenue Share by Players (2018-2023)
Table 37. Breakdown of Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 38. Market Position of Players in Irritable Bowel Syndrome (IBS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 39. Head Office of Key Irritable Bowel Syndrome (IBS) Players
Table 40. Irritable Bowel Syndrome (IBS) Market: Company Product Type Footprint
Table 41. Irritable Bowel Syndrome (IBS) Market: Company Product Application Footprint
Table 42. Irritable Bowel Syndrome (IBS) New Market Entrants and Barriers to Market Entry
Table 43. Irritable Bowel Syndrome (IBS) Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Irritable Bowel Syndrome (IBS) Consumption Value (USD Million) by Type (2018-2023)
Table 45. Global Irritable Bowel Syndrome (IBS) Consumption Value Share by Type (2018-2023)
Table 46. Global Irritable Bowel Syndrome (IBS) Consumption Value Forecast by Type (2024-2029)
Table 47. Global Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2023)
Table 48. Global Irritable Bowel Syndrome (IBS) Consumption Value Forecast by Application (2024-2029)
Table 49. North America Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2023) & (USD Million)
Table 50. North America Irritable Bowel Syndrome (IBS) Consumption Value by Type (2024-2029) & (USD Million)
Table 51. North America Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2023) & (USD Million)
Table 52. North America Irritable Bowel Syndrome (IBS) Consumption Value by Application (2024-2029) & (USD Million)
Table 53. North America Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2023) & (USD Million)
Table 54. North America Irritable Bowel Syndrome (IBS) Consumption Value by Country (2024-2029) & (USD Million)
Table 55. Europe Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Europe Irritable Bowel Syndrome (IBS) Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Europe Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2023) & (USD Million)
Table 58. Europe Irritable Bowel Syndrome (IBS) Consumption Value by Application (2024-2029) & (USD Million)
Table 59. Europe Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Irritable Bowel Syndrome (IBS) Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2023) & (USD Million)
Table 62. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Type (2024-2029) & (USD Million)
Table 63. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2023) & (USD Million)
Table 64. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Application (2024-2029) & (USD Million)
Table 65. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Region (2018-2023) & (USD Million)
Table 66. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value by Region (2024-2029) & (USD Million)
Table 67. South America Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2023) & (USD Million)
Table 68. South America Irritable Bowel Syndrome (IBS) Consumption Value by Type (2024-2029) & (USD Million)
Table 69. South America Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2023) & (USD Million)
Table 70. South America Irritable Bowel Syndrome (IBS) Consumption Value by Application (2024-2029) & (USD Million)
Table 71. South America Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2023) & (USD Million)
Table 72. South America Irritable Bowel Syndrome (IBS) Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Type (2018-2023) & (USD Million)
Table 74. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Type (2024-2029) & (USD Million)
Table 75. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Application (2018-2023) & (USD Million)
Table 76. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Application (2024-2029) & (USD Million)
Table 77. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Country (2018-2023) & (USD Million)
Table 78. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Value by Country (2024-2029) & (USD Million)
Table 79. Irritable Bowel Syndrome (IBS) Raw Material
Table 80. Key Suppliers of Irritable Bowel Syndrome (IBS) Raw Materials
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type in 2022
Figure 4. IBS-D Drug
Figure 5. IBS-C Drug
Figure 6. Others
Figure 7. Global Irritable Bowel Syndrome (IBS) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application in 2022
Figure 9. Women Picture
Figure 10. Men Picture
Figure 11. Global Irritable Bowel Syndrome (IBS) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Irritable Bowel Syndrome (IBS) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Irritable Bowel Syndrome (IBS) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Region in 2022
Figure 16. North America Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Irritable Bowel Syndrome (IBS) Revenue Share by Players in 2022
Figure 22. Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Irritable Bowel Syndrome (IBS) Market Share in 2022
Figure 24. Global Top 6 Players Irritable Bowel Syndrome (IBS) Market Share in 2022
Figure 25. Global Irritable Bowel Syndrome (IBS) Consumption Value Share by Type (2018-2023)
Figure 26. Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2024-2029)
Figure 27. Global Irritable Bowel Syndrome (IBS) Consumption Value Share by Application (2018-2023)
Figure 28. Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2024-2029)
Figure 29. North America Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 39. France Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Region (2018-2029)
Figure 46. China Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 49. India Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Irritable Bowel Syndrome (IBS) Consumption Value (2018-2029) & (USD Million)
Figure 63. Irritable Bowel Syndrome (IBS) Market Drivers
Figure 64. Irritable Bowel Syndrome (IBS) Market Restraints
Figure 65. Irritable Bowel Syndrome (IBS) Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome (IBS) in 2022
Figure 68. Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)
Figure 69. Irritable Bowel Syndrome (IBS) Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
